Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase <scp>III</scp> randomized, double‐blind, placebo‐controlled trial
Summary Purpose Brivaracetam ( BRV ) is a novel high‐affinity synaptic vesicle protein 2A ligand currently being investigated for the treatment of epilepsy. The purpose of this phase III study was to evaluate the efficacy and safety/tolerability of adjunctive BRV in adults with uncontrolled partial‐...
Uloženo v:
Hlavní autoři: | , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | angličtina |
Vydáno: |
2013
|
On-line přístup: | https://doi.org/10.1111/epi.12433 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/epi.12433 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|